Hansa Biopharma, “Hansa”, today announced positive high-level data from the 15-HMedIdeS-09 phase 2 trial that demonstrated imlifidase was safe and well tolerated when administered prior to standard of ...
In a cohort study conducted in Sweden, antibiotic-exposed newborns had a 29% increased risk of group B Streptococcus disease ...
Researchers in Norway studied rates of fatalities and long-term neurodevelopmental disorders among 866 infants diagnosed with GBS infection. Children with GBS meningitis died at higher rates than ...
Group B Streptococcus, which people may call group B strep (GBS), is a type of bacterium that causes GBS disease. GBS can lead to meningitis, which is an infection of the lining of the brain and ...
The FDA granted Pfizer a breakthrough therapy designation for its group B Streptococcus vaccine candidate for pregnant people to prevent GBS disease in newborns based on its ongoing phase 2 trial. GBS ...
Group B Streptococcus (also known as group B strep or GBS) is a common bacterium found in the rectum, digestive tract, and urinary tract of men and women. It’s also found in a woman’s vagina. GBS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback